Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer (Nature Communications, (2022), 13, 1, (3246), 10.1038/s41467-022-30666-0)

Autor: Coombes, R. C., Badman, P. D., Lozano-Kuehne, J. P., Liu, X., Macpherson, I. R., Zubairi, I., Baird, R. D., Rosenfeld, N., Garcia-Corbacho, J., Cresti, N., Plummer, R., Armstrong, A., Allerton, R., Landers, D., Nicholas, H., McLellan, L., Lim, A., Mouliere, F., Pardo, O. E., Ferguson, V., Seckl, M. J.

Publikováno v: Nature Communications, 14(1):260. Nature Publishing Group UK
Coombes, R C, Badman, P D, Lozano-Kuehne, J P, Liu, X, Macpherson, I R, Zubairi, I, Baird, R D, Rosenfeld, N, Garcia-Corbacho, J, Cresti, N, Plummer, R, Armstrong, A, Allerton, R, Landers, D, Nicholas, H, McLellan, L, Lim, A, Mouliere, F, Pardo, O E, Ferguson, V & Seckl, M J 2023, ' Author Correction : Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer (Nature Communications, (2022), 13, 1, (3246), 10.1038/s41467-022-30666-0) ', Nature Communications, vol. 14, no. 1, 260 . https://doi.org/10.1038/s41467-023-35969-4

In the original version of this article, the following author (Veronica Ferguson) was omitted from the author list. Author list, Author contributions and competing interests statements have now been updated in both the PDF and HTML versions of the ar

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7e2e046860bc756a455c52bf62b45aab
https://research.vumc.nl/en/publications/b3ee0e28-5d1b-4b34-b1e8-b9b33e588db9

Author Correction: Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer.

Autor: Coombes RC; Department of Surgery and Cancer, Imperial College London, London, UK. c.coombes@imperial.ac.uk., Badman PD; Department of Surgery and Cancer, Imperial College London, London, UK., Lozano-Kuehne JP; Department of Surgery and Cancer, Imperial College London, London, UK., Liu X; Department of Surgery and Cancer, Imperial College London, London, UK., Macpherson IR; Cancer Research UK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK., Zubairi I; Cancer Research UK Clinical Trials Unit, Beatson West of Scotland Cancer Centre, Glasgow, UK., Baird RD; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK., Rosenfeld N; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK., Garcia-Corbacho J; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK., Cresti N; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Plummer R; Sir Bobby Robson Cancer Trials Research Centre, Northern Centre for Cancer Care, Freeman Hospital, Newcastle, UK., Armstrong A; Breast Research Office, The Christie NHS Foundation Trust, Christie Hospital, Manchester, UK., Allerton R; C8 Admin Offices, Russell's Hall Hospital, Russells Hall, UK., Landers D; Astrazeneca, Cheshire, UK., Nicholas H; Department of Surgery and Cancer, Imperial College London, London, UK., McLellan L; ECMC Programme Office, Research and Innovation, Cancer Research UK, London, UK., Lim A; Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK., Mouliere F; Medical Oncology, Addenbrooke's Hospital, Breast Cancer Research Unit, Cancer Research UK Cambridge Centre, Cambridge, UK.; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Pathology, Cancer Centre Amsterdam, Amsterdam, The Netherlands., Pardo OE; Department of Surgery and Cancer, Imperial College London, London, UK., Ferguson V; Department of Surgery and Cancer, Imperial College London, London, UK., Seckl MJ; Department of Surgery and Cancer, Imperial College London, London, UK. m.seckl@imperial.ac.uk.

Publikováno v: Nature communications [Nat Commun] 2023 Jan 17; Vol. 14 (1), pp. 260. Date of Electronic Publication: 2023 Jan 17.